The Company

THE COMPANY

Our mission is to bring innovative technologies to practical diagnosis of diseases related with tumor processes

Initially, MiWendo solutions will develop and launch a novel endoscopy accessory medical device based on microwave technology targeting colorectal cancer early detection, with the final aim of reducing its incidence and mortality.

Grants

European Commission EIC Accelerator (Grant Agreement No. 960251)
Doctorados industriales (DIN2019-010857)
EIT Health Headstart (ID 2020-HS-0067)
Instituto de Salud Carlos III DTS (DTS17/00090)
Caixaimpulse (CI16-00058)
IC Producte (2016 PROD 00048)
IC Llavor (2014 LLAV 00016)
MiWEndo Solutions has received funding to carry out the project CPP2021/008536 – Disruptive technologies for early detection of colorectal cancer – TEDCRC” by MIC/AEI/10.13039/501100011033 and by European Union Next GenerationEU/PRTR
This project has received funding from the Eurostars-3 joint program with co-funding from CDTI and the European Union’s Horizon Europe Framework Program for Research and Innovation.

Patents

EP 3 195 786 A1
E 16152033 ES
E 16152033 IT
E 16152033 FR
E 16152033 DE
E 16152033 GB
JP6815405 (B2)
US11337618B2

Publications

Awards

Our Quality Policy

Company operates under a quality management system according to the standards ISO 13485 on medical devices.
MiWEndo has successfully passed a pilot clinical investigation of 15 patients, and we are now initiating a pivotal study involving 50 patients.
Regulatory market release for EU and US market is in process.
Initially, MiWendo Solutions will develop and launch a novel endoscopy accessory medical device based on microwave technology targeting colorectal cancer early detection, with the final aim of reducing its incidence and mortality.

In collaboration with

Supported by

Get in Touch

Have questions or need more information? We’re here to help! Click the button below to send us an email directly. We look forward to hearing from you.